603.40
price up icon1.29%   7.71
after-market After Hours: 603.40
loading
Mckesson Corporation stock is traded at $603.40, with a volume of 740.37K. It is up +1.29% in the last 24 hours and up +3.72% over the past month. McKesson Corp is one of three leading pharmaceutical wholesalers in the us engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the us pharmaceutical wholesale industry. Outside the us market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
See More
Previous Close:
$595.69
Open:
$598.51
24h Volume:
740.37K
Relative Volume:
0.94
Market Cap:
$75.62B
Revenue:
$344.58B
Net Income/Loss:
$2.83B
P/E Ratio:
27.63
EPS:
21.84
Net Cash Flow:
$1.63B
1W Performance:
+0.60%
1M Performance:
+3.72%
6M Performance:
+11.50%
1Y Performance:
+20.36%
1-Day Range:
Value
$583.55
$604.57
1-Week Range:
Value
$570.51
$612.98
52-Week Range:
Value
$464.42
$637.51

Mckesson Corporation Stock (MCK) Company Profile

Name
Name
Mckesson Corporation
Name
Phone
972-446-4800
Name
Address
6555 STATE HIGHWAY 161, IRVING, TX
Name
Employee
51,000
Name
Twitter
@McKesson
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
MCK's Discussions on Twitter

Compare MCK with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Distribution icon
MCK
Mckesson Corporation
603.40 75.62B 344.58B 2.83B 1.63B 21.84
Medical Distribution icon
COR
Cencora Inc
246.38 47.78B 303.19B 1.40B -638.10M 7.03
Medical Distribution icon
CAH
Cardinal Health Inc
127.20 30.98B 222.16B 1.31B -486.00M 5.36
Medical Distribution icon
HSIC
Henry Schein Inc
78.90 9.32B 12.50B 314.00M 421.00M 2.44
Medical Distribution icon
PDCO
Patterson Companies Inc
31.01 2.72B 6.55B 155.22M -823.13M 1.71

Mckesson Corporation Stock (MCK) Upgrades & Downgrades

Date Action Analyst Rating Change
Dec-04-24 Resumed Mizuho Neutral
Nov-07-24 Upgrade Robert W. Baird Neutral → Outperform
Sep-24-24 Downgrade Robert W. Baird Outperform → Neutral
Sep-05-24 Reiterated Leerink Partners Outperform
Aug-08-24 Reiterated Mizuho Neutral
Feb-26-24 Initiated Leerink Partners Outperform
Jan-03-24 Initiated Barclays Overweight
Dec-14-23 Initiated Wells Fargo Equal Weight
Mar-31-23 Initiated Citigroup Buy
Aug-22-22 Resumed Morgan Stanley Overweight
Jul-06-22 Downgrade Argus Buy → Hold
Jun-07-22 Upgrade Deutsche Bank Hold → Buy
Apr-01-22 Resumed Credit Suisse Outperform
Feb-04-22 Downgrade Deutsche Bank Buy → Hold
Jan-07-22 Upgrade Credit Suisse Neutral → Outperform
Nov-02-21 Reiterated Barclays Overweight
Nov-02-21 Reiterated BofA Securities Buy
Nov-02-21 Reiterated Evercore ISI Outperform
Nov-02-21 Reiterated Jefferies Buy
Mar-30-21 Upgrade Argus Hold → Buy
Nov-02-20 Upgrade Barclays Equal Weight → Overweight
Aug-04-20 Upgrade Deutsche Bank Hold → Buy
May-22-20 Upgrade Wolfe Research Peer Perform → Outperform
May-15-20 Upgrade UBS Neutral → Buy
Apr-23-20 Resumed Credit Suisse Neutral
Mar-18-20 Upgrade Goldman Neutral → Buy
Mar-13-20 Upgrade Guggenheim Neutral → Buy
Feb-07-20 Upgrade Robert W. Baird Neutral → Outperform
Jan-10-20 Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-12-19 Initiated Deutsche Bank Hold
Aug-05-19 Downgrade Wolfe Research Outperform → Peer Perform
Jul-22-19 Initiated Guggenheim Neutral
Jan-17-19 Initiated UBS Neutral
Oct-26-18 Reiterated Barclays Equal Weight
Jul-20-18 Downgrade Robert W. Baird Outperform → Neutral
May-29-18 Reiterated Leerink Partners Mkt Perform
Mar-08-18 Initiated Barclays Equal Weight
Feb-27-18 Resumed BofA/Merrill Buy
Feb-02-18 Reiterated Mizuho Neutral
Jan-24-18 Upgrade Jefferies Hold → Buy
View All

Mckesson Corporation Stock (MCK) Latest News

pulisher
Feb 10, 2025

$100 Invested In McKesson 20 Years Ago Would Be Worth This Much Today - Benzinga

Feb 10, 2025
pulisher
Feb 10, 2025

Citel Announces Launch of MCK – an AI-Powered Managed Service Provider - GlobeNewswire Inc.

Feb 10, 2025
pulisher
Feb 10, 2025

McKesson Third Quarter 2025 Earnings: EPS Misses Expectations - Simply Wall St

Feb 10, 2025
pulisher
Feb 08, 2025

McKesson Corp. outlook revised to positive, 'BBB+' rating affirmed: S&P Global - MSN

Feb 08, 2025
pulisher
Feb 07, 2025

McKesson Stock May Rise With PRISM Vision Holdings Acquisition - MSN

Feb 07, 2025
pulisher
Feb 07, 2025

Value-Based Healthcare Market Projected To Witness Substantial Growth, 2025-2032: McKesson Corporation, - EIN News

Feb 07, 2025
pulisher
Feb 06, 2025

McKesson (MCK) Q3 Earnings and Revenues Miss Estimates - MSN

Feb 06, 2025
pulisher
Feb 06, 2025

Pharmaceuticals Wholesale & Distribution Market to grow by USD 896.5 Billion from 2024-2028, Driven by Growing Global Pharmaceutical Sales, Report on How AI is Driving Market Transformation - Benzinga

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson’s Earnings Call Highlights Strong Growth - TipRanks

Feb 06, 2025
pulisher
Feb 06, 2025

Hold Rating for McKesson Amid Mixed Financial Performance and Uncertain Outlook - TipRanks

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson, AmerisourceBergen get judge to toss price-fixing lawsuit - MSN

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson, AmerisourceBergen's Joint Motion to Dismiss Antitrust Case Granted by Pennsylvania Judge - Marketscreener.com

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson to acquire majority stake in PRISM Vision for $850M - MSN

Feb 06, 2025
pulisher
Feb 06, 2025

Decoding McKesson's Options Activity: What's the Big Picture? - Benzinga

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson Corp (MCK) Q3 2025 Earnings Call Highlights: Strong Rev - GuruFocus.com

Feb 06, 2025
pulisher
Feb 06, 2025

Leerink Partners Adjusts Price Target on McKesson to $690 From $667 -February 06, 2025 at 11:32 am EST - Marketscreener.com

Feb 06, 2025
pulisher
Feb 06, 2025

Baird Adjusts Price Target on McKesson to $729 From $693 -February 06, 2025 at 11:28 am EST - Marketscreener.com

Feb 06, 2025
pulisher
Feb 06, 2025

Citi raises McKesson stock price target to $685 By Investing.com - Investing.com Nigeria

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson to acquire controlling interest in Prism Vision - Drug Store News

Feb 06, 2025
pulisher
Feb 06, 2025

Citi raises McKesson stock price target to $685 - Investing.com India

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson Corporation (NYSE:MCK) Q3 2025 Earnings Call Transcript - Insider Monkey

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson projects $32.55-$32.95 adjusted EPS for FY25, driven by specialty growth - MSN

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson's Q4 Revenue Grows by 17.8% but Falls Short of ExpectationsNews and Statistics - IndexBox, Inc.

Feb 06, 2025
pulisher
Feb 06, 2025

MCK Stock Down on Q3 Earnings & Sales Miss, Gross Margin Contracts - Yahoo Finance

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson Corp Reports Q3 Revenue of $95.3 Billion, Adjusted EPS of $8.03 Surpasses Estimates - GuruFocus.com

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson: Fiscal Q3 Earnings Snapshot - The Advocate

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson Corp (MCK) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Acquisitions - GuruFocus.com

Feb 06, 2025
pulisher
Feb 06, 2025

McKesson Corp (MCK) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance

Feb 06, 2025
pulisher
Feb 05, 2025

McKesson Reports Strong Growth and Raises EPS Guidance - TipRanks

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson (MCK) Q3 2025 Earnings Call Transcript - AOL

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson falls 3% on quarterly revenue miss, narrowed fiscal 2025 EPS outlook - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson shares fall as Q3 results miss estimates, guidance raised - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson Stumbles On Missed Revenue Target Despite High Demand - Finimize

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson misses third-quarter revenue estimates - MSN

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson misses third-quarter revenue estimates By Reuters - Investing.com

Feb 05, 2025
pulisher
Feb 05, 2025

Here's What Key Metrics Tell Us About McKesson (MCK) Q3 Earnings - Yahoo Finance

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson Exceeds EPS, Q3 Profit Surges - The Motley Fool

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson (NYSE:MCK) Misses Q4 Sales Targets - Yahoo Finance

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson: Fiscal Q3 Earnings Snapshot -February 05, 2025 at 04:33 pm EST - Marketscreener.com

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson shares fall as Q3 results miss estimates, guidance raised By Investing.com - Investing.com Australia

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson Fiscal Q3 Adjusted EPS, Revenue Increase; 2025 Outlook Updated -- Shares Down After Hours - Marketscreener.com

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson Q3 Earnings Report: What Investors Need to Know - Benzinga

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson earnings missed by $0.24, revenue fell short of estimates - Investing.com

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson Reports Q3 EPS of $8.03 on Revenue of $95.3 Billion, vs FactSet Analyst Consensus of $8.00/Share on Revenue of $96 Billion - Marketscreener.com

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson Narrows FY 2025 EPS View to $32.55-$32.95, vs Prior Guidance of $32.40-$33 and FactSet Analyst Consensus of $32.68/Share - Marketscreener.com

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson Corporation Reports Fiscal 2025 Third Quarter Results and Raises Full Year Adjusted EPS Guidance - The Bakersfield Californian

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson Q3 Earnings Surpass Expectations, Boosts 2025 Profit Outlook - StockTitan

Feb 05, 2025
pulisher
Feb 05, 2025

McKesson Q3 25 Earnings Conference Call At 4:30 PM ET - Nasdaq

Feb 05, 2025
pulisher
Feb 04, 2025

McKesson, Others Beat Indirect Drug Reseller Price-Fix Suit - Law360

Feb 04, 2025
pulisher
Feb 04, 2025

McKesson Paying $850M For Top Stake In Eye Health Co. - Law360

Feb 04, 2025
pulisher
Feb 04, 2025

Eyeing Ophthalmology in $850M Deal, Irving's McKesson To Snag Controlling Interest in PRISM Vision Holdings - dallasinnovates.com

Feb 04, 2025

Mckesson Corporation Stock (MCK) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
medical_distribution COR
$246.38
price down icon 0.61%
medical_distribution CAH
$127.20
price down icon 0.13%
$78.90
price down icon 0.13%
$31.01
price up icon 0.03%
medical_distribution OMI
$8.46
price down icon 2.20%
Cap:     |  Volume (24h):